The present invention provides pharmaceutical compositions comprising an anti-GM-CSF antibody, in particular MOR103, with pharmaceutically acceptable carriers, excipients or stabilizers, wherein the pharmaceutically acceptable carriers, excipients or stabilizers are a buffer which is histidine； a sugar which is sorbitol； and a non-ionic surfactant which is Tween-80； and the use of said compositions in the treatment of patients suffering from rheumatoid arthritis.
